e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Diffuse parenchymal lung disease I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of lymphadenopathy on pulmonary function tests in sarcoidosis
O. Araz, E. Yilmazel Ucar, Y. Aydin, M. Meral, Y. Bilen, F. Alper, A. M. Görgüner, M. Akgun (Erzurum, Turkey)
Source:
Annual Congress 2012 - Diffuse parenchymal lung disease I
Session:
Diffuse parenchymal lung disease I
Session type:
Thematic Poster Session
Number:
3625
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Araz, E. Yilmazel Ucar, Y. Aydin, M. Meral, Y. Bilen, F. Alper, A. M. Görgüner, M. Akgun (Erzurum, Turkey). Effects of lymphadenopathy on pulmonary function tests in sarcoidosis. Eur Respir J 2012; 40: Suppl. 56, 3625
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Pulmonary sarcoidosis
Definition and history of sarcoidosis
Related content which might interest you:
Correlation among pulmonary function tests and radiologic involvement in the monitoring of sarcoidosis
Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Year: 2020
Pulmonary function impairment in newly diagnosed pulmonary sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 135s
Year: 2001
Temporal changes in mediastinal lymphadenopathy in patients with idiopathic pulmonary fibrosis
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019
Pulmonary function tests in childhood scleroderma
Source: Eur Respir J 2006; 28: Suppl. 50, 307s
Year: 2006
Comprehensive evaluation of airway involvement in pulmonary sarcoidosis
Source: ERJ Open Res, 3 (1) 00105-2016; 10.1183/23120541.00105-2016
Year: 2017
Renal involvement in chronic pulmonary sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 550s
Year: 2005
Pulmonary disease in primary Sjögren´s syndrome: symptoms, pulmonary function tests and HRCT
Source: Eur Respir J 2004; 24: Suppl. 48, 487s
Year: 2004
Correlation of erithema nodosum with active pulmonary sarcoidosis based on bronchial biopsy data
Source: Eur Respir J 2003; 22: Suppl. 45, 265s
Year: 2003
Does concomitant extrapulmonary involvement changes characteristic features of pulmonary sarcoidosis?
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Pulmonary symptoms and pulmonary function tests of the welders
Source: Annual Congress 2009 - Air pollution and other exposures
Year: 2009
Effects of oral dual ERA therapy on pulmonary function testing and 6MWT in patients with idiopathic pulmonary fibrosis and pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012
Pathogenesis of pulmonary fibrosis in sarcoidosis
Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ?
Year: 2020
Evaluation of the functional parameters in scleroderma cases with pulmonary involvement
Source: Annual Congress 2009 - Respiratory physiology
Year: 2009
Pulmonary function tests as predictors of mortality in patients with sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
Gender differences in serial pulmonary function testing in idiopathic pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 579s
Year: 2007
Changes in pulmonary function tests following antibiotics in infants with pulmonary exacerbation of cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013
Assessing of the liver function tests in patients with acute pulmonary embolism
Source: Eur Respir J 2005; 26: Suppl. 49, 522s
Year: 2005
Differential diagnosis of pulmonary eosinophilia
Source: Eur Respir Monogr 2022; 95: 19-36
Year: 2022
Change in pulmonary function among patients with bronchiectasis with or without non-tuberculous mycobacterial pulmonary disease
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept